BC Week In Review | Jun 4, 2007
Company News

ViRexx Medical, National Research Council of Canada infectious news

The council will provide funding for its National Institute for Nanotechnology (NINT) to study the physical characteristics and immunological and nanoparticle-forming properties of VIR's Chimigen vaccines for HBV and HCV. The council's Defence Research and...
Items per page:
1 - 1 of 1